logo
  

CME Group CEO Craig Donohue To Retire; Names Phupinder Gill CEO - Quick Facts

CME Group Inc. (CME) announced that its Chief Executive Officer, Craig Donohue, will step down from the company when his contract expires in December 2012.

The company stated that its board has appointed Terrence Duffy, who is currently Executive Chairman, to the expanded role of Executive Chairman and President and current President Phupinder Gill to Chief Executive Officer when Donohue's contract expires.

Additionally, the company noted that its board extended Duffy's and Gill's contract agreements.

The company stated that the current Management Team also will remain in place.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT